![Supplemental Materials for Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients - Supplemental Materials for Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/936acbe9-f8de-4219-af9b-370ecce07c54/gr1_lrg.jpg)
Supplemental Materials for Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients -
![Bedienungsanleitung DeLonghi Nespresso Expert-Milk (Seite 58 von 194) (Deutsch, Englisch, Spanisch, Polnisch) Bedienungsanleitung DeLonghi Nespresso Expert-Milk (Seite 58 von 194) (Deutsch, Englisch, Spanisch, Polnisch)](https://www.libble.de/bestanden1/793871/bg37.png)
Bedienungsanleitung DeLonghi Nespresso Expert-Milk (Seite 58 von 194) (Deutsch, Englisch, Spanisch, Polnisch)
![PDF) The Effect of Intrapreneurship and Organizational Factors on the Innovation Performance in Hospital PDF) The Effect of Intrapreneurship and Organizational Factors on the Innovation Performance in Hospital](https://i1.rgstatic.net/publication/332078871_The_Effect_of_Intrapreneurship_and_Organizational_Factors_on_the_Innovation_Performance_in_Hospital/links/5e89be08299bf130797ce71a/largepreview.png)